Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03130868 · ClinicalTrials.gov registry record
Microbiome Changes in Severe Burns
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 2
- Enrollment target
NCT03130868: Completed study, sponsored by HealthPartners Institute.
NCT03130868 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03130868 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of the study is characterizing changes in the microbiome of severely-injured adult patients as they progress through stages of injury, reconstruction, and recovery from burns.
Primary Outcome
We will be analyzing the stool composition at the phyla level, looking at the percentages of the five major phyla - Firmicutes, Bacteroidetes, Proteobacteria, Acitonobacteria, and Fusobacteria
Interventions
- OTHER Characterizing changes in the microbiome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2018-07-02 |
What the finished NCT03130868 record still lists
NCT03130868 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Characterizing changes in the microbiome is the first listed.
NCT03130868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03130868 about?
NCT03130868 is a clinical study titled "Microbiome Changes in Severe Burns". The purpose of the study is characterizing changes in the microbiome of severely-injured adult patients as they progress through stages of injury, reconstruction, and recovery from burns.
What is the current status of trial NCT03130868?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2017-05-15. Estimated completion is 2018-07-02.
What interventions are being tested in trial NCT03130868?
The interventions under investigation include: Characterizing changes in the microbiome (OTHER).
Who is sponsoring clinical trial NCT03130868?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI